Education
About Us
Working with TipRanks
Follow Us
Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ:VNDA
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 216.10M | $ 198.77M | $ 192.64M | $ 254.38M | $ 268.68M |
| Gross Profit | $ 203.06M | $ 187.46M | $ 177.84M | $ 230.10M | $ 243.05M |
| Operating Income | $ -151.17M | $ -40.66M | $ -13.95M | $ 6.33M | $ 42.16M |
| EBITDA | $ -139.25M | $ -32.53M | $ -10.94M | $ 9.06M | $ 45.01M |
| Net Income | $ -220.47M | $ -18.90M | $ 2.51M | $ 6.28M | $ 33.15M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 263.85M | $ 374.64M | $ 388.26M | $ 466.86M | $ 432.81M |
| Total Assets | $ 488.95M | $ 656.20M | $ 648.44M | $ 634.25M | $ 593.79M |
| Total Debt | $ 12.62M | $ 12.36M | $ 9.40M | $ 11.14M | $ 12.37M |
| Net Debt | $ -72.23M | $ -89.96M | $ -126.42M | $ -123.89M | $ -39.70M |
| Total Liabilities | $ 161.76M | $ 117.66M | $ 103.53M | $ 107.05M | $ 88.86M |
| Stockholders' Equity | $ 327.19M | $ 538.55M | $ 544.91M | $ 527.20M | $ 504.93M |
| Cash Flow | |||||
| Free Cash Flow | $ -110.44M | $ -16.25M | $ 12.42M | $ 31.30M | $ 63.66M |
| Operating Cash Flow | $ -109.44M | $ -15.76M | $ 12.80M | $ 31.98M | $ 64.21M |
| Investing Cash Flow | $ 94.86M | $ -17.43M | $ -12.06M | $ 49.92M | $ -76.70M |
| Financing Cash Flow | $ -2.91M | $ -155.00K | $ 0.00 | $ 734.00K | $ 3.55M |